$73.38
00.00%
Pre-Market: Jul 19, 6:18 PM EDT
15 minutes delayed
Comments
Loading...
HealthEquity
HQYNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
HealthEquity (NASDAQ:HQY) Stock, Analyst Ratings, Price Targets, Forecasts
HealthEquity Inc has a consensus price target of $95.71 based on the ratings of 17 analysts. The high is $110 issued by Wells Fargo on June 20, 2024. The low is $72 issued by Deutsche Bank on September 7, 2023. The 3 most-recent analyst ratings were released by B of A Securities, Wells Fargo, and Raymond James on July 3, 2024, June 20, 2024, and June 7, 2024, respectively. With an average price target of $106.67 between B of A Securities, Wells Fargo, and Raymond James, there's an implied 45.36% upside for HealthEquity Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
Wells Fargo
Raymond James
Keybanc
Barrington Research
1calculated from analyst ratings
Analyst Ratings for HealthEquity
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/03/2024 | Buy Now | 43.09% | B of A Securities | Allen Lutz | $105 → $105 | Maintains | Buy | Get Alert |
| 06/20/2024 | Buy Now | 49.9% | Wells Fargo | Stan Berenshteyn | $107 → $110 | Maintains | Overweight | Get Alert |
| 06/07/2024 | Buy Now | 43.09% | Raymond James | C. Gregory Peters | $100 → $105 | Maintains | Outperform | Get Alert |
| 06/05/2024 | Buy Now | 36.28% | Keybanc | Scott Schoenhaus | $95 → $100 | Maintains | Overweight | Get Alert |
| 06/04/2024 | Buy Now | 45.82% | Wells Fargo | Stan Berenshteyn | $105 → $107 | Maintains | Overweight | Get Alert |
| 06/04/2024 | Buy Now | 43.09% | Barrington Research | Alexander Paris | $100 → $105 | Maintains | Outperform | Get Alert |
| 06/04/2024 | Buy Now | 25.37% | RBC Capital | Sean Dodge | $92 → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 06/04/2024 | Buy Now | 43.09% | B of A Securities | Allen Lutz | $97 → $105 | Maintains | Buy | Get Alert |
| 06/04/2024 | Buy Now | 43.09% | JMP Securities | Constantine Davides | $101 → $105 | Maintains | Market Outperform | Get Alert |
| 06/04/2024 | Buy Now | 41.73% | Baird | Mark Marcon | $98 → $104 | Maintains | Outperform | Get Alert |
| 04/04/2024 | Buy Now | 37.64% | JMP Securities | Constantine Davides | → $101 | Initiates | → Market Outperform | Get Alert |
| 04/02/2024 | Buy Now | 47.18% | JP Morgan | Anne Samuel | $86 → $108 | Maintains | Overweight | Get Alert |
| 03/22/2024 | Buy Now | 29.46% | Keybanc | Scott Schoenhaus | $85 → $95 | Maintains | Overweight | Get Alert |
| 03/22/2024 | Buy Now | 36.28% | Barrington Research | Alexander Paris | → $100 | Maintains | Outperform | Get Alert |
| 03/20/2024 | Buy Now | 49.9% | BTIG | David Larsen | $100 → $110 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | 25.37% | RBC Capital | Sean Dodge | $90 → $92 | Maintains | Outperform | Get Alert |
| 03/20/2024 | Buy Now | 32.19% | B of A Securities | Allen Lutz | $93 → $97 | Maintains | Buy | Get Alert |
| 02/23/2024 | Buy Now | 22.65% | RBC Capital | Sean Dodge | $77 → $90 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | 41.73% | Barclays | — | $84 → $104 | Maintains | Overweight | Get Alert |
| 12/13/2023 | Buy Now | 29.46% | Raymond James | C. Gregory Peters | $90 → $95 | Maintains | Outperform | Get Alert |
| 12/06/2023 | Buy Now | 26.74% | Wells Fargo | Stan Berenshteyn | $89 → $93 | Maintains | Overweight | Get Alert |
| 12/04/2023 | Buy Now | 15.84% | Barrington Research | Alexander Paris | → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 12/01/2023 | Buy Now | -0.52% | JP Morgan | Anne Samuel | $81 → $73 | Maintains | Overweight | Get Alert |
| 09/21/2023 | Buy Now | 18.56% | Baird | Mark Marcon | $79 → $87 | Upgrade | Neutral → Outperform | Get Alert |
| 09/07/2023 | Buy Now | -1.88% | Deutsche Bank | George Hill | $71 → $72 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | 15.84% | Barrington Research | Alexander Paris | $80 → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 09/06/2023 | Buy Now | 4.93% | RBC Capital | Sean Dodge | $75 → $77 | Maintains | Outperform | Get Alert |
| 06/07/2023 | Buy Now | -3.24% | Deutsche Bank | George Hill | $69 → $71 | Maintains | Buy | Get Alert |
| 06/06/2023 | Buy Now | 2.21% | RBC Capital | Sean Dodge | → $75 | Reiterates | → Outperform | Get Alert |
| 06/01/2023 | Buy Now | 9.02% | Barrington Research | Alexander Paris | → $80 | Reiterates | Outperform → Outperform | Get Alert |
| 03/24/2023 | Buy Now | -5.97% | Deutsche Bank | George Hill | $72 → $69 | Maintains | Buy | Get Alert |
| 03/22/2023 | Buy Now | 9.02% | Barrington Research | Alexander Paris | → $80 | Reiterates | → Outperform | Get Alert |
| 03/22/2023 | Buy Now | 2.21% | RBC Capital | Sean Dodge | → $75 | Reiterates | → Outperform | Get Alert |
| 02/03/2023 | Buy Now | 21.29% | Wells Fargo | Stan Berenshteyn | $101 → $89 | Maintains | Overweight | Get Alert |
| 01/24/2023 | Buy Now | -1.88% | Deutsche Bank | George Hill | $68 → $72 | Maintains | Buy | Get Alert |
| 12/12/2022 | Buy Now | 15.84% | Raymond James | C. Gregory Peters | $75 → $85 | Maintains | Outperform | Get Alert |
| 12/07/2022 | Buy Now | 28.1% | Guggenheim | Sandy Draper | $89 → $94 | Maintains | Buy | Get Alert |
| 12/07/2022 | Buy Now | 37.64% | Wells Fargo | Stan Berenshteyn | $104 → $101 | Maintains | Overweight | Get Alert |
| 12/05/2022 | Buy Now | 2.21% | RBC Capital | Sean Dodge | $70 → $75 | Maintains | Outperform | Get Alert |
| 10/25/2022 | Buy Now | 41.73% | Wells Fargo | Stan Berenshteyn | $100 → $104 | Maintains | Overweight | Get Alert |
| 10/21/2022 | Buy Now | 4.93% | Goldman Sachs | Cindy Motz | $64 → $77 | Upgrade | Sell → Neutral | Get Alert |
| 09/16/2022 | Buy Now | 15.84% | Keybanc | Scott Schoenhaus | → $85 | Initiates | → Overweight | Get Alert |
| 09/13/2022 | Buy Now | 36.28% | Wells Fargo | Stan Berenshteyn | $95 → $100 | Maintains | Overweight | Get Alert |
| 09/12/2022 | Buy Now | 2.21% | Raymond James | C. Gregory Peters | $70 → $75 | Maintains | Outperform | Get Alert |
| 09/08/2022 | Buy Now | -7.33% | Deutsche Bank | George Hill | $67 → $68 | Maintains | Buy | Get Alert |
| 09/07/2022 | Buy Now | -8.69% | Baird | Mark Marcon | $47 → $67 | Maintains | Neutral | Get Alert |
| 07/12/2022 | Buy Now | -19.6% | Goldman Sachs | Cindy Motz | → $59 | Initiates | → Sell | Get Alert |
| 06/08/2022 | Buy Now | -8.69% | Deutsche Bank | George Hill | $66 → $67 | Maintains | Buy | Get Alert |
| 06/07/2022 | Buy Now | 3.57% | SVB Leerink | Stephanie Davis | $67 → $76 | Maintains | Outperform | Get Alert |
| 04/11/2022 | Buy Now | 29.46% | Wells Fargo | Stan Berenshteyn | → $95 | Initiates | → Overweight | Get Alert |
| 04/07/2022 | Buy Now | 21.29% | Guggenheim | Sandy Draper | → $89 | Initiates | → Buy | Get Alert |
| 03/30/2022 | Buy Now | 15.84% | BTIG | David Larsen | → $85 | Upgrade | Neutral → Buy | Get Alert |
| 03/28/2022 | Buy Now | 9.02% | Jefferies | Glen Santangelo | $62 → $80 | Maintains | Buy | Get Alert |
| 03/24/2022 | Buy Now | -10.06% | Deutsche Bank | George Hill | $62 → $66 | Maintains | Buy | Get Alert |
| 02/24/2022 | Buy Now | -15.51% | Deutsche Bank | George Hill | $52 → $62 | Maintains | Buy | Get Alert |
| 12/21/2021 | Buy Now | -23.68% | JP Morgan | Anne Samuel | $82 → $56 | Maintains | Overweight | Get Alert |
| 12/08/2021 | Buy Now | -29.14% | Deutsche Bank | George Hill | — | Maintains | Buy | Get Alert |
| 12/07/2021 | Buy Now | -4.61% | Raymond James | C. Gregory Peters | — | Downgrade | Strong Buy → Outperform | Get Alert |
| 12/07/2021 | Buy Now | -4.61% | RBC Capital | Sean Dodge | — | Maintains | Outperform | Get Alert |
| 12/02/2021 | Buy Now | -7.33% | Jefferies | Glen Santangelo | — | Initiates | → Buy | Get Alert |
| 09/21/2021 | Buy Now | 2.21% | Deutsche Bank | George Hill | — | Maintains | Buy | Get Alert |
| 09/09/2021 | Buy Now | 9.02% | SVB Leerink | — | — | Upgrade | Market Perform → Outperform | Get Alert |
FAQ
What is the target price for HealthEquity (HQY) stock?
The latest price target for HealthEquity (NASDAQ:HQY) was reported by B of A Securities on July 3, 2024. The analyst firm set a price target for $105.00 expecting HQY to rise to within 12 months (a possible 43.09% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HealthEquity (HQY)?
The latest analyst rating for HealthEquity (NASDAQ:HQY) was provided by B of A Securities, and HealthEquity maintained their buy rating.
When was the last upgrade for HealthEquity (HQY)?
The last upgrade for HealthEquity Inc happened on September 21, 2023 when Baird raised their price target to $87. Baird previously had a neutral for HealthEquity Inc.
When was the last downgrade for HealthEquity (HQY)?
The last downgrade for HealthEquity Inc happened on December 7, 2021 when Raymond James changed their price target from $90 to $70 for HealthEquity Inc.
When is the next analyst rating going to be posted or updated for HealthEquity (HQY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HealthEquity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HealthEquity was filed on July 3, 2024 so you should expect the next rating to be made available sometime around July 3, 2025.
Is the Analyst Rating HealthEquity (HQY) correct?
While ratings are subjective and will change, the latest HealthEquity (HQY) rating was a maintained with a price target of $105.00 to $105.00. The current price HealthEquity (HQY) is trading at is $73.38, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.